TFPI inhibitors and methods of use
Details for Australian Patent Application No. 2009327338 (hide)
International Classifications
Event Publications
30 June 2011 PCT application entered the National Phase
PCT publication WO2010/071894 Priority application(s): WO2010/071894
15 September 2011 Assignment before Grant
Baxter Healthcare S.A.; 3B Pharmaceuticals GmbH; Baxter International Inc.; Cosmix Molecular Biologicals GmbH The application has been assigned to Baxter International Inc.; Baxter Healthcare S.A.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser